π€ GenAI helps treat academic anxiety in trials
A hybrid human-GenAI single-session exposure program was tested for academic anxiety in two randomized controlled trials. The research involved 425 participants across trials registered in April 2025 and April 2026. The intervention showed greater improvements in immediate and two-week follow-up anxiety compared to both control groups. Participants found the program to be safe and acceptable during the study period. These findings suggest human-GenAI collaboration can safely offer evidence-based care. π§